Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes / Cannon, C.p., Blazing, M.a., Giugliano, R.p., Mccagg, A., White, J.a., Theroux, P., Darius, H., Lewis, B.s., Ophuis, T.o., Jukema, J.w., De Ferrari, G.m., Ruzyllo, W., De Lucca, P., Im, K., Bohula, E.a., Reist, C., Wiviott, S.d., Tershakovec, A.m., Musliner, T.a., Braunwald, E., et al.. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 372:25(2015), pp. 2387-97-2397. [10.1056/NEJMoa1410489]
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cianflone, DMembro del Collaboration Group
2015-01-01
Abstract
Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.| File | Dimensione | Formato | |
|---|---|---|---|
|
nejmoa1410489.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
574.22 kB
Formato
Adobe PDF
|
574.22 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
nejmoa1410489_appendix.pdf
solo gestori archivio
Tipologia:
Altro materiale allegato
Licenza:
Tutti i diritti riservati
Dimensione
1.24 MB
Formato
Adobe PDF
|
1.24 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
